Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


CEL SCI CORP (CVM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 TALOR EYAL (Chief Scientific Officer) has filed a Form 4 on CEL SCI CORP
Txns: Granted 1,920 shares @ $1.25, valued at $2.4k
10/03/2023 4 PRICHEP PATRICIA B (Senior Vice President) has filed a Form 4 on CEL SCI CORP
Txns: Granted 3,432 shares @ $1.25, valued at $4.3k
10/03/2023 4 KERSTEN GEERT R (CEO) has filed a Form 4 on CEL SCI CORP
Txns: Granted 3,960 shares @ $1.25, valued at $5k
08/10/2023 4 Naughton Gail K (Director) has filed a Form 4 on CEL SCI CORP
Txns: Granted 85,000 options @ $1.36, valued at $115.6k
08/10/2023 4 Watson Robert Eugene (Director) has filed a Form 4 on CEL SCI CORP
Txns: Granted 64,000 options @ $1.36, valued at $87k
08/10/2023 4 BAILLAVOINE BRUNO JEAN-MARIE (Director) has filed a Form 4 on CEL SCI CORP
Txns: Granted 64,000 options @ $1.36, valued at $87k
08/10/2023 4 YOUNG PETER R (Director) has filed a Form 4 on CEL SCI CORP
Txns: Granted 64,000 options @ $1.36, valued at $87k
08/10/2023 4 CIPRIANO JOHN (Senior Vice President) has filed a Form 4 on CEL SCI CORP
Txns: Granted 65,000 options @ $1.36, valued at $88.4k
08/10/2023 4 TALOR EYAL (Chief Scientific Officer) has filed a Form 4 on CEL SCI CORP
Txns: Granted 182,000 options @ $1.36, valued at $247.5k
08/10/2023 4 PRICHEP PATRICIA B (Senior Vice President) has filed a Form 4 on CEL SCI CORP
Txns: Granted 167,000 options @ $1.36, valued at $227.1k
08/10/2023 4 KERSTEN GEERT R (CEO) has filed a Form 4 on CEL SCI CORP
Txns: Granted 250,000 options @ $1.36, valued at $340k
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/20/2023 8-K Quarterly results
07/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/18/2023 8-K Quarterly results
07/17/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
07/17/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/14/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CEL-SCI CONCLUDES POSITIVE MEETING WITH U.S. FDA CONCERNING MULTIKINE’S APPROVAL FOR HEAD & NECK CANCER"
07/12/2023 8-K Quarterly results
07/03/2023 4 TALOR EYAL (Chief Scientific Officer) has filed a Form 4 on CEL SCI CORP
Txns: Granted 995 shares @ $2.41, valued at $2.4k
07/03/2023 4 PRICHEP PATRICIA B (Senior Vice President) has filed a Form 4 on CEL SCI CORP
Txns: Granted 1,780 shares @ $2.41, valued at $4.3k
07/03/2023 4 KERSTEN GEERT R (CEO) has filed a Form 4 on CEL SCI CORP
Txns: Granted 2,053 shares @ $2.41, valued at $4.9k
05/23/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/02/2023 8-K Quarterly results
05/01/2023 8-K Quarterly results
04/19/2023 8-K Quarterly results
04/06/2023 4 TALOR EYAL (Chief Scientific Officer) has filed a Form 4 on CEL SCI CORP
Txns: Granted 1,034 shares @ $2.32, valued at $2.4k
04/06/2023 4 PRICHEP PATRICIA B (Senior Vice President) has filed a Form 4 on CEL SCI CORP
Txns: Granted 1,849 shares @ $2.32, valued at $4.3k
04/06/2023 4 KERSTEN GEERT R (CEO) has filed a Form 4 on CEL SCI CORP
Txns: Granted 2,133 shares @ $2.32, valued at $4.9k
03/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CEL-SCI’s Multikine Phase 3 Cancer Study Shows 43% Survival Extension"
02/08/2023 SC 13G/A STATE STREET CORP reports a 0.5% stake in EXIT FILING CEL-SCI CORP
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy